Amgen finds no synergy with Synergen


In 1994, Amgen Inc. acquired Synergen Inc.'s product pipeline and $120 million in cash for $240 million. Nearly three years later, nothing in that pipeline has progressed past Phase I/II testing, and now AMGN is looking for a partner to help share the costs of developing all but one product candidate.


Read the full 537 word article

How to gain access

Continue reading with a
two-week free trial.